Retroperitoneal liposarcoma: the role of adjuvant radiation therapy and the prognostic factors

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the benefit of adjuvant radiation therapy (RT) for retroperitoneal liposarcoma (RPLS) following gross tumor removal.
Materials and Methods: We reviewed 77 patients with primary RPLS surgically treated between January 2000 and December 2013. Cases with gross residual disease were excluded. Tumor grade was evaluated according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC) system. Adjuvant RT was delivered to 32 patients (42%) using external beam RT alone. Median follow-up time was 36 months (range, 5 to 169).
Results: Among 77 patients, 33 (43%) presented with well-differentiated, 31 (40%) with de-differentiated, 8 (10%) with myxoid/round and 4 (5%) with pleomorphic morphology. The RT group included less well-differentiated subtype than surgery group (28% vs. 53%). During follow up, 34 patients (44%) showed local recurrence. Local recurrence rate was lower in the RT group (38%) compared to the surgery group (49%). The 3-year local control rate (LC) was 55.6%, and the 3-year overall survival (OS) was 82.1%. Tumor histology and FNCLCC grade were significantly associated with local recurrence. There was no statistical significance of adding adjuvant RT in LC (p = 0.312). However, patients with tumor histology other than well-differentiated subtype showed marginally decreased local recurrence rate after adjuvant RT (3-year LC, RT 43.9% vs. no RT 35.3%; p = 0.087).
Conclusion: RPLS patients receiving RT experienced less local recurrence. We suggest that the addition of adjuvant RT may be related to improvement of LCs, especially in patients with non-favorable histologic subtypes.

참고문헌 (Reference)

1 Kinne DW, "Treatment of primary and recurrent retroperitoneal liposarcoma: twentyfive- year experience at Memorial Hospital" 31 : 53-64, 1973

2 Zhou Z, "Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient" 145 : 426-431, 2010

3 Lewis JJ, "Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution" 228 : 355-365, 1998

4 Ballo MT, "Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment" 67 : 158-163, 2007

5 Raut CP, "Retroperitoneal sarcomas: combinedmodality treatment approaches" 94 : 81-87, 2006

6 Storm FK, "Retroperitoneal sarcomas: a reappraisal of treatment" 17 : 1-7, 1981

7 Lee SY, "Retroperitoneal liposarcomas: the experience of a tertiary Asian center" 9 : 12-, 2011

8 Mettlin C, "Results of the national soft-tissue sarcoma registry" 19 : 224-227, 1982

9 van Doorn RC, "Resectable retroperitoneal soft tissue sarcomas: the effect of extent of resection and postoperative radiation therapy on local tumor control" 73 : 637-642, 1994

10 Yang JC, "Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity" 16 : 197-203, 1998

11 Sampath S, "Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients" 101 : 345-350, 2010

12 Tuan J, "Radiation therapy for retroperitoneal sarcoma" 119 : 790-802, 2014

13 Stoeckle E, "Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group" 92 : 359-368, 2001

14 Bonvalot S, "Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control" 27 : 31-37, 2009

15 Papanicolaou N, "Primary retroperitoneal neoplasms: how close can we come in making the correct diagnosis" 14 : 221-228, 1992

16 Nussbaum DP, "Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity scorematched analysis of a nationwide clinical oncology database" 17 : 966-975, 2016

17 Gronchi A, "Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets" 31 : 1649-1655, 2013

18 Jaques DP, "Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum" 212 : 51-59, 1990

19 Pisters PW, "Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma" 14 : 859-868, 1996

20 van Dalen T, "Long-term prognosis of primary retroperitoneal soft tissue sarcoma" 33 : 234-238, 2007

21 Singer S, "Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma" 238 : 358-370, 2003

22 van de Rijn M, "Genetics of soft tissue tumors" 1 : 435-466, 2006

23 Ghadimi MP, "Diagnosis, management, and outcome of patients with dedifferentiated liposarcoma systemic metastasis" 18 : 3762-3770, 2011

24 Mullinax JE, "Current diagnosis and management of retroperitoneal sarcoma" 18 : 177-187, 2011

25 Strander H, "A systematic overview of radiation therapy effects in soft tissue sarcomas" 42 : 516-531, 2003